Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma

Conference contribution


Publication Details

Author(s): Bengs S, Becker E, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Britzen-Laurent N, Von Boehmer L, Knuth A, Tuomisto A, Makinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Vavricka SR, Halama M, Croner RS, Christoph J, Jenkins G, Sheppard D, Stürzl M, Fried M, Rogler G, Scharl M
Publication year: 2017
Volume: 147
Pages range: 9S-9S
ISSN: 1424-7860
eISSN: 1424-3997


FAU Authors / FAU Editors

Christoph, Jan
Lehrstuhl für Medizinische Informatik
Stürzl, Michael Prof. Dr.
Professur für Molekulare und Experimentelle Chirurgie


External institutions with authors

Hamad Medical Corporation
Oulun Yliopisto / University of Oulo
Rockefeller University
See-Spital Horgen
Stadtspital Triemli / Triemli Hospital
Universitätsspital Basel
Universitätsspital Zürich (USZ)
University of California San Francisco (UCSF)
University of Nottingham


How to cite

APA:
Bengs, S., Becker, E., Spalinger, M.R., Raselli, T., Kasper, S., Lang, S.,... Scharl, M. (2017). Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma. (pp. 9S-9S).

MLA:
Bengs, Susan, et al. "Beta-6-Integrin serves as a novel tumor marker and therapeutic target for colorectal carcinoma." 2017. 9S-9S.

BibTeX: 

Last updated on 2019-26-03 at 16:23